Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
FBLG
#3764
FibroBiologics, Inc. Common Stock
0.3
3
+17.86%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+17.86%
Aylık değişim
-8.33%
6 aylık değişim
-45.90%
Yıllık değişim
-72.73%
Önceki kapanış
0.2
8
Open
0.3
3
Bid
Ask
Low
0.3
3
High
0.3
3
Hacim
3
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
FBLG
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
33.92 M
35.09 M
37.74 M
40.86 M
48.26 M
66.52 M
193.38 M
Valuation ratios
Enterprise value
99.27 M
70.95 M
25.77 M
17.26 M
23.21 M
10.31 M
76.55 M
Price to earnings ratio
-5.24
-5.88
-4.29
-1.73
-1.14
-0.54
-7.69
Price to sales ratio
—
71.47
—
—
4.73
2.95
—
Price to cash flow ratio
9.33
5.52
2.4
1.49
1.26
0.61
5.77
Price to book ratio
9.56
24.04
2.98
2.48
3.17
1.63
10.26
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.05
0.08
0.43
0.33
0.66
0.34
1.77
Return on equity %
0.18
0.48
2.11
5.42
46.22
0.53
54.28
Return on invested capital %
—
—
—
—
—
-403.37
—
Gross margin %
—
100
100
100
100
100
400
Operating margin %
—
403.37
287.87
244.29
-3 759.7
2 055.56
-1 171.99
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
141.63
315.5
253.43
-4 311.94
2 574.6
-1 168.41
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
1.23
1.12
1.14
0.93
0.78
3.61
6.45
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
0.07
0.11
0.15
-0.01
0.01
0.26
Solvency ratios
Debt to assets ratio
—
0.58
—
—
—
—
—
Debt to equity ratio
—
3.46
—
—
—
—
—
Long term debt to total assets ratio
0.01
0.56
0.51
0.58
0.52
0
1.61
Long term debt to total equity ratio
0.04
3.35
2.48
9.38
36.58
0
48.45
Per share metrics
Operating cash flow per share
0.08
0.09
0.14
0.1
0.09
0.07
0.41
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
0.29
—
—
—
—
—
Cash per share
0.23
0.43
0.24
0.23
0.11
0.11
0.69
Net current asset value per share
0.24
0.43
0.25
0.26
0.12
0.14
0.78
Tangible book value per share
0.08
0.08
0.06
0.02
0
0.14
0.23
Working capital per share
0.05
0.05
0.03
-0.02
-0.03
0.1
0.08
Book value per share
0.08
0.08
0.06
0.02
0
0.14
0.23
Haberler
H.C. 웨인라이트, FibroBiologics 목표 주가 $4로 하향
H.C. Wainwright cuts FibroBiologics stock price target to $4
피보바이오로직스, 주식 병합 및 워런트 발행 승인
FibroBiologics shareholders approve reverse stock split and warrant share issuances
FibroBiologics, 나스닥 상장 유지 위한 유예 기간 확보
FibroBiologics gets Nasdaq extension to meet listing rules
파이브로바이오로직스, 2026년 1분기 당뇨병성 족부 궤양 임상 시험 개시
FibroBiologics to begin diabetic foot ulcer clinical trial in Q1 2026
파이브로바이오로직스, 디스크 퇴행 치료제 긍정적 결과 발표
FibroBiologics reports positive results for disc degeneration therapy
파이브로바이오로직스, 나스닥 상장 폐지 통보…청문회 요청
FibroBiologics receives Nasdaq delisting notice, requests hearing to appeal